Healthcare · Profile from Healthcare Research Companion
Zipline International Inc.
The autonomous drone logistics company that began in 2016 by parachuting blood to rural hospitals in Rwanda, grew into a government-contracted medical supply network across Ghana, Nigeria, Kenya and Côte d'Ivoire, and then used that record to build a US home-delivery business for retailers and health systems. It is the clearest case of an emerging market serving as the proving ground for a technology later sold in rich countries. It is also a lesson in what happens when a health ministry that signed a take-or-pay contract stops paying. Reported valuation: $7.6bn (January 2026), with talks reported at ~$20bn (September 2026, verify).
At a glance
- Founded
- March 2014, Half Moon Bay, California, out of the robotics start-up Romotive (founded 2011); first commercial operations October 2016 in Rwanda
- Founders
- Keller Rinaudo Cliffton (CEO), Keenan Wyrobek, Ryan Oksenhorn and William Hetzler
- Headquarters
- South San Francisco, California; operating hubs ("distribution centres" or "nests") in Rwanda, Ghana, Nigeria, Kenya, Côte d'Ivoire, Japan (through Toyota Tsusho) and several US metros
- Ownership / structure
- Private, venture-backed Delaware corporation; national operating subsidiaries (for example Zipline Ghana Limited) hold government contracts
- Leadership (2026)
- Keller Rinaudo Cliffton, co-founder and CEO; Caitlin Burton, CEO of Zipline Africa (named November 2025); other co-founders and senior executives have changed roles over time (verify current executive team)
- Segment and buyer
- Global health logistics and last-mile delivery. Buyers: national and state governments (ministries of health, blood services, medical stores) under multi-year service contracts; US health systems (Novant, Intermountain, Cleveland Clinic, Michigan Medicine, MultiCare, OhioHealth and others, announced); retailers and restaurants (Walmart, GNC, Sweetgreen and others, announced) paying per delivery or per programme
- Scale
- 1 million commercial deliveries and ~70m autonomous miles (April 2024); 2 million deliveries and ~120m autonomous miles (January 2026), company-reported; network serving ~5,000 health facilities in five African countries (company, November 2025; Ghana alone ~2,000+ facilities, reported)
- Capital raised / valuation
- Roughly ~$1.5bn+ of equity raised by 2026 (estimate from reported rounds; verify). Reported marks: ~$1.2bn (2019), ~$2.7bn (2021), $4.2bn (Series F, $330m, April 2023), ~$5bn (2024), $7.6bn ($600m led by Valor Equity Partners, January 2026; extended by $200m to ~$800m in March 2026); talks to raise ~$1bn at ~$20bn reported by Bloomberg (September 2026, not confirmed closed)
- Signature moves (incl. failures)
- Pivot from consumer robots to medical drones (2014); Rwanda blood delivery (2016); Ghana national network (2019) and the controversy over its cost; growth rounds and unicorn status (2019–2023); Novant Health COVID waiver and FAA Part 135 (2020–22); Nigeria, Kenya and Côte d'Ivoire contracts (2021–23); Platform 2 home delivery (announced 2023, launched 2025); Ghana arrears and suspension of three hubs (2025); US State Department $150m pay-for-performance award (2025); $7.6bn round and US scale-up (2026)
10 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2014
Founding and Medical Drone Pivot
Founding / pivot
2016
Rwanda Blood Delivery Launch
Launch / government contract
2019
Ghana National Network Launch
Launch / government contract
2019
Growth Capital and Unicorn Valuation
Funding rounds
2020
Novant Health and US Hospital Logistics
Partnership / regulatory approval
2021
Nigeria Kenya Cote dIvoire Expansion
Expansion / government contracts
2023
Platform 2 Home Delivery
Product launch
2025
Ghana Arrears and Hub Suspension
Contract dispute / restructuring
2025
State Department 150M Africa Award
Government funding / partnership
2026
Series H and US Scale Up
Funding round / expansion